北京锦篮基因科技有限公司是一家以AAV载体递送技术介导的基因治疗药物开发 为核心业务的国家高新技术企业，以推动中国罕见病基因药物从基础走向临床和市场 为使命，造福患者及家庭。公司专注于遗传性神经肌肉疾病、遗传代谢疾病、溶酶体 疾病以及眼科疾病等领域基因治疗药物开发，并通过推进罕见病基因药物研发、生产 以及临床应用，更深入认识生命健康，将基因治疗技术及产品从罕见病过渡到慢性病 和其它重大疾病的治疗和康复，加速推进基因治疗药物被患者真正可及。

 Beijing GeneCradle Technology Co., Ltd. is a pioneering Chinese national  high-tech enterprise at the forefront of gene therapy drugs development mediated  by cutting-edge AAV vector delivery technology. With a focus on hereditary  neuromuscular diseases, genetic metabolic diseases, lysosomal storage disorders,  and ophthalmic diseases, we relentlessly pursue the development of innovative gene  therapy solutions. By fostering research and development, optimizing production  processes, and facilitating clinical application of these rare disease treatment, we  gain a profounder comprehension of life, health, and the potential of gene therapy.  Moreover, we have transcended the boundaries of rare diseases, applying our  expertise in gene therapy technology and products to the treatment and rehabilitation  of chronic illness and other significant heath challenges. This groundbreaking  approach accelerates the accessibility of gene therapy, ensuring they become a  reality for patients worldwide.

地址：北京市北京经济技术开发区经海三路35号院3号楼4层

4th Floor, Building 3, No.35, Jinghai 3rd Road, Beijing

Economic and Technological Development Zone, Beijing